Homology Medicines (STU:35H) Current Accrued Expense : €1.16 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Homology Medicines Current Accrued Expense?

Homology Medicines's Current Accrued Expense for the quarter that ended in Dec. 2023 was €1.16 Mil.

Homology Medicines's quarterly Current Accrued Expense declined from Jun. 2023 (€13.14 Mil) to Sep. 2023 (€8.48 Mil) and declined from Sep. 2023 (€8.48 Mil) to Dec. 2023 (€1.16 Mil).

Homology Medicines's annual Current Accrued Expense increased from Dec. 2021 (€3.19 Mil) to Dec. 2022 (€12.05 Mil) but then declined from Dec. 2022 (€12.05 Mil) to Dec. 2023 (€1.16 Mil).

Homology Medicines Current Accrued Expense Historical Data

The historical data trend for Homology Medicines's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Homology Medicines Current Accrued Expense Chart

Homology Medicines Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2.78

2.39

3.19

12.05

1.16

Homology Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															12.05	9.69	13.14	8.48	1.16

Homology Medicines Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Homology Medicines Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Homology Medicines's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Homology Medicines (STU:35H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (STU:35H) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

FIXX:USA

Address

One Patriots Park, Bedford, MA, USA, 01730

Website

https://www.homologymedicines.com

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (STU:35H) Headlines

No Headlines